Endocrine therapies in breast cancer /:
Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of endocrine therapy is central to the management of t...
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Oxford ; New York :
Oxford University Press,
2007.
|
| Schriftenreihe: | Oxford oncology library.
|
| Schlagworte: | |
| Online-Zugang: | DE-862 DE-863 |
| Zusammenfassung: | Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of endocrine therapy is central to the management of their disease. Tamoxifen has long been the mainstay of endocrine therapy in this group of patients. However, there is mounting evidence showing that the aromatase inhibitors are able toreduce overall oestrogen levels and appear to be better tolerated over a long term than tamoxifen. New and emerging. |
| Beschreibung: | 1 online resource (viii, 120 pages) : illustrations |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 9780191575174 0191575178 0191739871 9780191739873 0199606994 9780199606993 1283580756 9781283580755 9786613893208 661389320X |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn801405943 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 120723s2007 enka ob 001 0 eng d | ||
| 010 | |z 2007038907 | ||
| 040 | |a N$T |b eng |e pn |c N$T |d E7B |d OCLCQ |d OCLCF |d OCLCQ |d NLGGC |d OCLCO |d YDXCP |d OCLCQ |d EBLCP |d IDEBK |d OCLCO |d OCLCQ |d AZK |d OCLCO |d LOA |d STBDS |d OCLCA |d COCUF |d TOA |d OCLCO |d AGLDB |d OCLCO |d MOR |d CCO |d PIFAG |d ZCU |d OCLCO |d OCLCQ |d MERUC |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCO |d STF |d OCLCO |d WRM |d VNS |d OCLCO |d VTS |d NRAMU |d ICG |d VT2 |d AU@ |d OCLCO |d OCLCQ |d WYU |d OCLCA |d REC |d OCLCO |d DKC |d OCLCQ |d UX1 |d OCLCQ |d OCLCA |d UKCRE |d UKAHL |d AJS |d OCLCQ |d OCLCO |d OCLCQ |d QGK |d OCLCO |d OCLCL |d SXB |d OCLCQ | ||
| 019 | |a 801363649 |a 961618370 |a 962602314 |a 966212272 |a 988501072 |a 992094670 |a 1037791981 |a 1038614370 |a 1045514218 |a 1055366187 |a 1066545960 |a 1081286810 |a 1153554442 |a 1259216388 | ||
| 020 | |a 9780191575174 |q (electronic bk.) | ||
| 020 | |a 0191575178 |q (electronic bk.) | ||
| 020 | |z 9780199218141 | ||
| 020 | |z 0199218145 | ||
| 020 | |a 0191739871 | ||
| 020 | |a 9780191739873 | ||
| 020 | |a 0199606994 | ||
| 020 | |a 9780199606993 | ||
| 020 | |a 1283580756 | ||
| 020 | |a 9781283580755 | ||
| 020 | |a 9786613893208 | ||
| 020 | |a 661389320X | ||
| 035 | |a (OCoLC)801405943 |z (OCoLC)801363649 |z (OCoLC)961618370 |z (OCoLC)962602314 |z (OCoLC)966212272 |z (OCoLC)988501072 |z (OCoLC)992094670 |z (OCoLC)1037791981 |z (OCoLC)1038614370 |z (OCoLC)1045514218 |z (OCoLC)1055366187 |z (OCoLC)1066545960 |z (OCoLC)1081286810 |z (OCoLC)1153554442 |z (OCoLC)1259216388 | ||
| 050 | 4 | |a RC280.B8 |b E523 2007eb | |
| 060 | 4 | |a WP 870 |b E56 2007 | |
| 072 | 7 | |a HEA |x 039030 |2 bisacsh | |
| 072 | 7 | |a MED |x 062000 |2 bisacsh | |
| 082 | 7 | |a 616.99/449071 |2 22 | |
| 049 | |a MAIN | ||
| 245 | 0 | 0 | |a Endocrine therapies in breast cancer / |c edited by Aman U. Buzdar. |
| 260 | |a Oxford ; |a New York : |b Oxford University Press, |c 2007. | ||
| 300 | |a 1 online resource (viii, 120 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Oxford oncology library | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Selection of patients for endocrine therapies / W. Fraser Symmans and Lajos Pusztai -- Ovarian ablation / Kellie l. Jones -- Antioestrogens / John F. Forbes -- Aromatase inhibitors in early and advanced disease / Laura Boehnke Michaud -- Fulvestrant in metastatic disease / Amit Agrawal, J.F.R. Robertson, and K.L. Cheung -- Progestins and androgens / Janet l. Espirito -- Combined endocrine and chemotherapy in breast cancer / Ishmael Jaiyesimi [and others] -- Hormone replacement therapy in patients with a prior history of breast cancer / Gilbert G. Fareau and Rena Vassilopoulou-Sellin -- Chemoprevention / Saheenah Dawood and Jack Cuzick. | |
| 588 | 0 | |a Print version record. | |
| 520 | |a Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of endocrine therapy is central to the management of their disease. Tamoxifen has long been the mainstay of endocrine therapy in this group of patients. However, there is mounting evidence showing that the aromatase inhibitors are able toreduce overall oestrogen levels and appear to be better tolerated over a long term than tamoxifen. New and emerging. | ||
| 546 | |a English. | ||
| 650 | 0 | |a Breast |x Cancer |x Hormone therapy. | |
| 650 | 0 | |a Breast |x Cancer |x Endocrine aspects. | |
| 650 | 1 | 2 | |a Breast Neoplasms |x drug therapy |
| 650 | 2 | 2 | |a Antineoplastic Agents, Hormonal |x therapeutic use |
| 650 | 6 | |a Sein |x Cancer |x Hormonothérapie. | |
| 650 | 6 | |a Sein |x Cancer |x Aspect endocrinien. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Cancer. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Oncology. |2 bisacsh | |
| 650 | 7 | |a Breast |x Cancer |x Endocrine aspects |2 fast | |
| 650 | 7 | |a Breast |x Cancer |x Hormone therapy |2 fast | |
| 700 | 1 | |a Buzdar, Aman U. | |
| 758 | |i has work: |a Endocrine therapies in breast cancer (Text) |1 https://id.oclc.org/worldcat/entity/E39PCY97mpDWDjvdr8DyBgp8rV |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Endocrine therapies in breast cancer. |d Oxford ; New York : Oxford University Press, 2007 |z 9780199218141 |w (DLC) 2007038907 |w (OCoLC)74966478 |
| 830 | 0 | |a Oxford oncology library. |0 http://id.loc.gov/authorities/names/n2007184279 | |
| 966 | 4 | 0 | |l DE-862 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=467600 |3 Volltext |
| 966 | 4 | 0 | |l DE-863 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=467600 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH37530475 | ||
| 938 | |a EBL - Ebook Library |b EBLB |n EBL975599 | ||
| 938 | |a ebrary |b EBRY |n ebr10581391 | ||
| 938 | |a EBSCOhost |b EBSC |n 467600 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 389320 | ||
| 938 | |a Oxford University Press USA |b OUPR |n EDZ0000091504 | ||
| 938 | |a YBP Library Services |b YANK |n 9316034 | ||
| 938 | |a YBP Library Services |b YANK |n 12890069 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-862 | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn801405943 |
|---|---|
| _version_ | 1826941984096387072 |
| adam_text | |
| any_adam_object | |
| author2 | Buzdar, Aman U. |
| author2_role | |
| author2_variant | a u b au aub |
| author_facet | Buzdar, Aman U. |
| author_sort | Buzdar, Aman U. |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC280 |
| callnumber-raw | RC280.B8 E523 2007eb |
| callnumber-search | RC280.B8 E523 2007eb |
| callnumber-sort | RC 3280 B8 E523 42007EB |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | Selection of patients for endocrine therapies / W. Fraser Symmans and Lajos Pusztai -- Ovarian ablation / Kellie l. Jones -- Antioestrogens / John F. Forbes -- Aromatase inhibitors in early and advanced disease / Laura Boehnke Michaud -- Fulvestrant in metastatic disease / Amit Agrawal, J.F.R. Robertson, and K.L. Cheung -- Progestins and androgens / Janet l. Espirito -- Combined endocrine and chemotherapy in breast cancer / Ishmael Jaiyesimi [and others] -- Hormone replacement therapy in patients with a prior history of breast cancer / Gilbert G. Fareau and Rena Vassilopoulou-Sellin -- Chemoprevention / Saheenah Dawood and Jack Cuzick. |
| ctrlnum | (OCoLC)801405943 |
| dewey-full | 616.99/449071 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/449071 |
| dewey-search | 616.99/449071 |
| dewey-sort | 3616.99 6449071 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05107cam a2200793 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn801405943</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">120723s2007 enka ob 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2007038907</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">EBLCP</subfield><subfield code="d">IDEBK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">LOA</subfield><subfield code="d">STBDS</subfield><subfield code="d">OCLCA</subfield><subfield code="d">COCUF</subfield><subfield code="d">TOA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AGLDB</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MOR</subfield><subfield code="d">CCO</subfield><subfield code="d">PIFAG</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCO</subfield><subfield code="d">STF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">WRM</subfield><subfield code="d">VNS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">VTS</subfield><subfield code="d">NRAMU</subfield><subfield code="d">ICG</subfield><subfield code="d">VT2</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCA</subfield><subfield code="d">REC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UX1</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">UKCRE</subfield><subfield code="d">UKAHL</subfield><subfield code="d">AJS</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">QGK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield><subfield code="d">SXB</subfield><subfield code="d">OCLCQ</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">801363649</subfield><subfield code="a">961618370</subfield><subfield code="a">962602314</subfield><subfield code="a">966212272</subfield><subfield code="a">988501072</subfield><subfield code="a">992094670</subfield><subfield code="a">1037791981</subfield><subfield code="a">1038614370</subfield><subfield code="a">1045514218</subfield><subfield code="a">1055366187</subfield><subfield code="a">1066545960</subfield><subfield code="a">1081286810</subfield><subfield code="a">1153554442</subfield><subfield code="a">1259216388</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780191575174</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0191575178</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9780199218141</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0199218145</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0191739871</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780191739873</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0199606994</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780199606993</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1283580756</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781283580755</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9786613893208</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">661389320X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)801405943</subfield><subfield code="z">(OCoLC)801363649</subfield><subfield code="z">(OCoLC)961618370</subfield><subfield code="z">(OCoLC)962602314</subfield><subfield code="z">(OCoLC)966212272</subfield><subfield code="z">(OCoLC)988501072</subfield><subfield code="z">(OCoLC)992094670</subfield><subfield code="z">(OCoLC)1037791981</subfield><subfield code="z">(OCoLC)1038614370</subfield><subfield code="z">(OCoLC)1045514218</subfield><subfield code="z">(OCoLC)1055366187</subfield><subfield code="z">(OCoLC)1066545960</subfield><subfield code="z">(OCoLC)1081286810</subfield><subfield code="z">(OCoLC)1153554442</subfield><subfield code="z">(OCoLC)1259216388</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC280.B8</subfield><subfield code="b">E523 2007eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">WP 870</subfield><subfield code="b">E56 2007</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039030</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">062000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.99/449071</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Endocrine therapies in breast cancer /</subfield><subfield code="c">edited by Aman U. Buzdar.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Oxford ;</subfield><subfield code="a">New York :</subfield><subfield code="b">Oxford University Press,</subfield><subfield code="c">2007.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (viii, 120 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Oxford oncology library</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Selection of patients for endocrine therapies / W. Fraser Symmans and Lajos Pusztai -- Ovarian ablation / Kellie l. Jones -- Antioestrogens / John F. Forbes -- Aromatase inhibitors in early and advanced disease / Laura Boehnke Michaud -- Fulvestrant in metastatic disease / Amit Agrawal, J.F.R. Robertson, and K.L. Cheung -- Progestins and androgens / Janet l. Espirito -- Combined endocrine and chemotherapy in breast cancer / Ishmael Jaiyesimi [and others] -- Hormone replacement therapy in patients with a prior history of breast cancer / Gilbert G. Fareau and Rena Vassilopoulou-Sellin -- Chemoprevention / Saheenah Dawood and Jack Cuzick.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of endocrine therapy is central to the management of their disease. Tamoxifen has long been the mainstay of endocrine therapy in this group of patients. However, there is mounting evidence showing that the aromatase inhibitors are able toreduce overall oestrogen levels and appear to be better tolerated over a long term than tamoxifen. New and emerging.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Hormone therapy.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Endocrine aspects.</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Breast Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Antineoplastic Agents, Hormonal</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Sein</subfield><subfield code="x">Cancer</subfield><subfield code="x">Hormonothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Sein</subfield><subfield code="x">Cancer</subfield><subfield code="x">Aspect endocrinien.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">Cancer.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Oncology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Endocrine aspects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Hormone therapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Buzdar, Aman U.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Endocrine therapies in breast cancer (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCY97mpDWDjvdr8DyBgp8rV</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Endocrine therapies in breast cancer.</subfield><subfield code="d">Oxford ; New York : Oxford University Press, 2007</subfield><subfield code="z">9780199218141</subfield><subfield code="w">(DLC) 2007038907</subfield><subfield code="w">(OCoLC)74966478</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Oxford oncology library.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2007184279</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-862</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=467600</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-863</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=467600</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH37530475</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBL - Ebook Library</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL975599</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10581391</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">467600</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">389320</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Oxford University Press USA</subfield><subfield code="b">OUPR</subfield><subfield code="n">EDZ0000091504</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">9316034</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">12890069</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-862</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn801405943 |
| illustrated | Illustrated |
| indexdate | 2025-03-18T14:20:47Z |
| institution | BVB |
| isbn | 9780191575174 0191575178 0191739871 9780191739873 0199606994 9780199606993 1283580756 9781283580755 9786613893208 661389320X |
| language | English |
| oclc_num | 801405943 |
| open_access_boolean | |
| owner | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| physical | 1 online resource (viii, 120 pages) : illustrations |
| psigel | ZDB-4-EBA FWS_PDA_EBA ZDB-4-EBA |
| publishDate | 2007 |
| publishDateSearch | 2007 |
| publishDateSort | 2007 |
| publisher | Oxford University Press, |
| record_format | marc |
| series | Oxford oncology library. |
| series2 | Oxford oncology library |
| spelling | Endocrine therapies in breast cancer / edited by Aman U. Buzdar. Oxford ; New York : Oxford University Press, 2007. 1 online resource (viii, 120 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Oxford oncology library Includes bibliographical references and index. Selection of patients for endocrine therapies / W. Fraser Symmans and Lajos Pusztai -- Ovarian ablation / Kellie l. Jones -- Antioestrogens / John F. Forbes -- Aromatase inhibitors in early and advanced disease / Laura Boehnke Michaud -- Fulvestrant in metastatic disease / Amit Agrawal, J.F.R. Robertson, and K.L. Cheung -- Progestins and androgens / Janet l. Espirito -- Combined endocrine and chemotherapy in breast cancer / Ishmael Jaiyesimi [and others] -- Hormone replacement therapy in patients with a prior history of breast cancer / Gilbert G. Fareau and Rena Vassilopoulou-Sellin -- Chemoprevention / Saheenah Dawood and Jack Cuzick. Print version record. Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of endocrine therapy is central to the management of their disease. Tamoxifen has long been the mainstay of endocrine therapy in this group of patients. However, there is mounting evidence showing that the aromatase inhibitors are able toreduce overall oestrogen levels and appear to be better tolerated over a long term than tamoxifen. New and emerging. English. Breast Cancer Hormone therapy. Breast Cancer Endocrine aspects. Breast Neoplasms drug therapy Antineoplastic Agents, Hormonal therapeutic use Sein Cancer Hormonothérapie. Sein Cancer Aspect endocrinien. HEALTH & FITNESS Diseases Cancer. bisacsh MEDICAL Oncology. bisacsh Breast Cancer Endocrine aspects fast Breast Cancer Hormone therapy fast Buzdar, Aman U. has work: Endocrine therapies in breast cancer (Text) https://id.oclc.org/worldcat/entity/E39PCY97mpDWDjvdr8DyBgp8rV https://id.oclc.org/worldcat/ontology/hasWork Print version: Endocrine therapies in breast cancer. Oxford ; New York : Oxford University Press, 2007 9780199218141 (DLC) 2007038907 (OCoLC)74966478 Oxford oncology library. http://id.loc.gov/authorities/names/n2007184279 |
| spellingShingle | Endocrine therapies in breast cancer / Oxford oncology library. Selection of patients for endocrine therapies / W. Fraser Symmans and Lajos Pusztai -- Ovarian ablation / Kellie l. Jones -- Antioestrogens / John F. Forbes -- Aromatase inhibitors in early and advanced disease / Laura Boehnke Michaud -- Fulvestrant in metastatic disease / Amit Agrawal, J.F.R. Robertson, and K.L. Cheung -- Progestins and androgens / Janet l. Espirito -- Combined endocrine and chemotherapy in breast cancer / Ishmael Jaiyesimi [and others] -- Hormone replacement therapy in patients with a prior history of breast cancer / Gilbert G. Fareau and Rena Vassilopoulou-Sellin -- Chemoprevention / Saheenah Dawood and Jack Cuzick. Breast Cancer Hormone therapy. Breast Cancer Endocrine aspects. Breast Neoplasms drug therapy Antineoplastic Agents, Hormonal therapeutic use Sein Cancer Hormonothérapie. Sein Cancer Aspect endocrinien. HEALTH & FITNESS Diseases Cancer. bisacsh MEDICAL Oncology. bisacsh Breast Cancer Endocrine aspects fast Breast Cancer Hormone therapy fast |
| title | Endocrine therapies in breast cancer / |
| title_auth | Endocrine therapies in breast cancer / |
| title_exact_search | Endocrine therapies in breast cancer / |
| title_full | Endocrine therapies in breast cancer / edited by Aman U. Buzdar. |
| title_fullStr | Endocrine therapies in breast cancer / edited by Aman U. Buzdar. |
| title_full_unstemmed | Endocrine therapies in breast cancer / edited by Aman U. Buzdar. |
| title_short | Endocrine therapies in breast cancer / |
| title_sort | endocrine therapies in breast cancer |
| topic | Breast Cancer Hormone therapy. Breast Cancer Endocrine aspects. Breast Neoplasms drug therapy Antineoplastic Agents, Hormonal therapeutic use Sein Cancer Hormonothérapie. Sein Cancer Aspect endocrinien. HEALTH & FITNESS Diseases Cancer. bisacsh MEDICAL Oncology. bisacsh Breast Cancer Endocrine aspects fast Breast Cancer Hormone therapy fast |
| topic_facet | Breast Cancer Hormone therapy. Breast Cancer Endocrine aspects. Breast Neoplasms drug therapy Antineoplastic Agents, Hormonal therapeutic use Sein Cancer Hormonothérapie. Sein Cancer Aspect endocrinien. HEALTH & FITNESS Diseases Cancer. MEDICAL Oncology. Breast Cancer Endocrine aspects Breast Cancer Hormone therapy |
| work_keys_str_mv | AT buzdaramanu endocrinetherapiesinbreastcancer |